Pharmaceutical Data Integrity (DI) Solutions
Implementation of DI support required in pharmaceutical manufacturing sites, such as 'Part 11 functionality Ethernet connection' and 'Active Directory integration'.
The Part 11 compliant weight sorting machines from Anritsu, including those for capsules, are designed to output data in accordance with industry standards such as FDA 21 CFR Part 11, Annex 11, and PIC/S PI 041, which require qualified person certification, audit trails, and data integrity. ✅ Part 11 Functionality with Ethernet Connection Audit trails and statistical data can be output via Ethernet as non-editable PDF reports and encrypted files. Backup and restoration of various data and equipment parameter settings can also be easily performed via Ethernet. ✅ Active Directory Integration Users can log onto the device using information registered on the Active Directory server. Each operator can log in to any device using the same user code and password. *This feature is optional. *Active Directory is a trademark of Microsoft Corporation. For more details, please refer to the links below or feel free to contact us. If you have any questions or requests, please do not hesitate to reach out to us.
Inquire About This Product
basic information
【Features】 - Part 11 functionality with Ethernet connection: Outputs audit trails and statistical data via Ethernet in non-editable PDF reports and encrypted files. - Active Directory integration: Allows users registered on the Active Directory server to log in to the device. 【Our Strengths】 Our company is based on "measurement" technology and develops its business primarily in the fields of information communication and food and pharmaceuticals. Leveraging years of experience and know-how in weight inspection solutions, foreign matter inspection solutions, and more, we support our customers' DI compliance efforts.
Price range
Delivery Time
Applications/Examples of results
**Achievements** ■ Weight Inspection Solutions (Cumulative sales: over 95,000 units*) ■ Foreign Matter Inspection Solutions (Cumulative sales: over 60,000 units*) ■ Composite Inspection Solutions (Cumulative sales: over 15,000 units*) ■ Data Management Solutions (Cumulative sales: over 2,500 units) ■ Countries of Product Shipment: Over 80 countries* Our products are used by many customers, from major pharmaceutical producing countries to emerging markets. *As of the end of March 2023 For more details, please refer to the PDF document or feel free to contact us.
catalog（2）
Download All Catalogs
Company information
［Trusted Worldwide: Anritsu Inspection Systems］ Anritsu inspection systems are used globally to ensure product safety and quality across a wide range of industries and applications. Key Features of Our Weighing & Inspection Solutions ●Contaminant Detection Detects foreign materials such as metal, bone, glass, ceramic, and more. ●Content Verification Checks for missing or excess items, presence/absence, and item counts. ●Package Inspection Identifies issues like product caught in seals and defective printing. ●Weight Inspection Performs quantitative checks and grading for consistent product quality. ●Production & Quality Management Enables centralized control, real-time monitoring, statistical analysis, and traceability through our proprietary system, QUICCA. ［Supporting the Pharmaceutical Industry Since 1964］ Anritsu delivered its first checkweigher to a pharmaceutical manufacturer in 1964. Inspired by the industry's strict standards for quality control, we have continuously evolved our technologies to meet advanced quality assurance needs. Today, Anritsu Infivis works closely with pharmaceutical partners to address complex challenges in manufacturing and compliance. ［In-House Development for Superior Performance］ All Anritsu products—including weighcells—are developed in-house. This commitment to innovation is reflected in the high performance of our electromagnetic force balance weighcells. ［Enhancing Quality and Productivity in Pharma］ Anritsu’s inspection technologies contribute to improved quality and efficiency in pharmaceutical manufacturing and R&D environments.
